B-CELL MALIGNANCIES
Clinical trials for B-CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new B-CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for B-CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Swiss hospital tests 'Double-Target' immune therapy for tough blood cancers
Disease control Not yet recruitingThis early-stage trial is testing the safety of a new, locally-made CAR-T cell therapy designed to attack two targets (CD19 and CD20) on cancer cells. It is for adults with advanced B-cell leukemias or lymphomas who have relapsed after or cannot access standard treatments, includ…
Matched conditions: B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Cancer-Fighting mRNA tech tested in patients out of options
Disease control Not yet recruitingThis early-stage study is testing a new experimental drug called WGb-0301 for people with advanced B-cell cancers (like certain leukemias and lymphomas) that have come back or stopped responding to standard treatments. The drug uses mRNA technology—similar to that in some COVID-1…
Matched conditions: B-CELL MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Scientists search for hidden clues in blood cancers
Knowledge-focused Not yet recruitingThis study aims to better understand certain types of blood cancers by measuring the levels of two specific proteins (CD85d and CD305) on cancer cells. Researchers will analyze samples from 180 newly diagnosed patients with B-cell cancers, including leukemia and lymphoma. The goa…
Matched conditions: B-CELL MALIGNANCIES
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC